TissueGnostics

Executive Summary

TissueGnostics is an Austrian company providing integrated whole-slide imaging and AI-driven quantitative image analysis solutions for biomedical research. Its TissueFAXS systems and StrataQuest software enable spatial phenotyping and multiplex tissue analysis, with applications in oncology and immunology. The technology allows researchers to quantify cellular interactions and biomarker expression within the tissue microenvironment, addressing the growing demand for high-plex spatial biology in drug discovery and translational research. As a private company with no disclosed funding or revenue, TissueGnostics operates in the competitive digital pathology and AI diagnostics landscape, but its established product portfolio and adoption in academic and pharma labs suggest a solid niche position. The company could expand into clinical diagnostics pending regulatory clearances, potentially unlocking a larger addressable market.

Upcoming Catalysts (preview)

• TBDFDA clearance for clinical diagnostic use of TissueFAXS/StrataQuest40% success
• TBDMajor pharma partnership for spatial biomarker analysis in clinical trials60% success
• TBDLaunch of next-generation AI analysis module with multi-omics integration70% success